1NICE clinical gqideline 34.Hypertension: management of hypertension in adults in primary care. Mondon: Natinal Institute for Health and Clinical Excellence. 2006. 被引量：1
2Leehat P. Adrenergic beta- blockers and heart failure. Arch Mal Coeur Vaiss 1995,88(suppll) :611. 被引量：1
3Bristow MR. Mechanism of action of B- blocking agents in heart failure.Am J Cardiol 1997,80:261. 被引量：1
4Neutel JM, Smith DH, Ram CV et al . Applient of ambulatory blood pressure monitoring in differentiating between antihypertensive agents.Am J Med, 1993,94:181. 被引量：1
5WHO ISH Hypertension Guideline. 1999 Who/ISH guideline for the management of hypertension. Hypertension 1999, 17 (20) : 151. 被引量：1
6Michel E Safar, Albert Fournier. Letter by safar and Fournier regarding article, “Differential impact of blood pressure lowering drugs on central aortic pressure and clinical outcome: principal result of the conduit artery function evaluation (CAF6) study”. Circulation, 2006,114: 593. 被引量：1
7Wright JC,Looney SW. Prevalence of positive oder's maneuver in 3387 persons screened for the systolic hypertension in the elderly program (SHEP).J Hum Hypertens 1997,11:285. 被引量：1
8Hansson L, Zanchetti A, Carruthers G et al . For the HOT study group. Effects of intensive blood- pressure lowering and low- dose aspirin in patients with hypertension:Principal results of the hypertension optimal treatment (HOT) randomized trial.Lancet 1998,351:1753. 被引量：1
9Pepine CJ, Hanberg- Thurmond E,Marks RG et al.Rational and design of the international verapamil SR/Trandopril study (INVEST) .An internet- based randomized trial in coronary artery disease patients with hypertension. J Am Coll Cardiol 1998,32:1228. 被引量：1
